Which document identifies the IRB/IEC approval (dated and documented) of trial related documents?

Which document identifies the IRB/IEC approval (dated and documented) of trial related documents?

• A. Dated, Documented Approval/Favorable Opinion of IRB/IEC of Trial Related Documents
• B. Any Revision to Trial Documents
• C. Investigator's Brochure Updates
• D. Pre-Trial Monitoring Report

Answer: (A)

In Good Clinical Practice, every trial-related document that will be used with participants must have evidence of IRB/IEC review and approval, including the date. The document that captures this evidence is specifically the record of Dated, Documented Approval or Favorable Opinion from the IRB/IEC for the trial related documents. This ensures there is a clear, traceable record showing that each document—the protocol, consent forms, patient information sheets, case report forms, etc.—was reviewed and approved before use, with the approval date documented for auditability. The other options don’t serve this purpose: revisions to trial documents may be approved later and don’t alone confirm initial approvals for all trial documents; investigator’s brochure updates and pre-trial monitoring reports pertain to product information and monitoring findings, not the formal recorded approvals of each trial document.

In Good Clinical Practice, every trial-related document that will be used with participants must have evidence of IRB/IEC review and approval, including the date. The document that captures this evidence is specifically the record of Dated, Documented Approval or Favorable Opinion from the IRB/IEC for the trial related documents. This ensures there is a clear, traceable record showing that each document—the protocol, consent forms, patient information sheets, case report forms, etc.—was reviewed and approved before use, with the approval date documented for auditability.

The other options don’t serve this purpose: revisions to trial documents may be approved later and don’t alone confirm initial approvals for all trial documents; investigator’s brochure updates and pre-trial monitoring reports pertain to product information and monitoring findings, not the formal recorded approvals of each trial document.